ArticleTherapeutic advances in hematology2026
Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.
Yutian Lei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.